OverviewChartNewsTraderScreen

JP Morgan Call 140 PSX 20.06.2025/  DE000JK46P48  /

EUWAX
30/07/2024  11:53:54 Chg.-0.18 Bid19:20:10 Ask19:20:10 Underlying Strike price Expiration date Option type
2.07EUR -8.00% 2.50
Bid Size: 50,000		 2.54
Ask Size: 50,000		 Phillips 66 140.00 USD 20/06/2025 Call
Newsfile Corp 04/07 King Fuels Announces Expansion Across the U.S.
GlobeNewswire 01/07 Phillips Edison & Company Announces Appointment of Devin Murphy to Board of Directors
GlobeNewswire 27/06 Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire 25/06 FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technolog...
GlobeNewswire 21/06 Lifetime Brands, Inc. Announces Results of 2024 Annual Meeting
GlobeNewswire 20/06 The International Food Information Council (IFIC) Releases Annual Food & Health Survey Revealing Ris...
GlobeNewswire 18/06 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
GlobeNewswire 17/06 Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire 17/06 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 13/06 Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
GlobeNewswire 13/06 FibroBiologics Set to Join Russell 2000® Index
GlobeNewswire 12/06 Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire 06/06 FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
GlobeNewswire 05/06 EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 30/05 Celebrate Life’s Sweet Surprises in New Children’s Book THE ICE CREAM TREE
GlobeNewswire 29/05 Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference
GlobeNewswire 22/05 Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire 20/05 Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire 16/05 Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire 16/05 First Wave BioPharma Changes Name to Entero Therapeutics
GlobeNewswire 16/05 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 15/05 FibroBiologics Announces 2024 Annual Meeting of Stockholders
Newsfile Corp 15/05 King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...
GlobeNewswire 14/05 FibroBiologics Files 2024 First Quarter Report
GlobeNewswire 14/05 Kontrolmatik Technologies and Pomega Standardize Operations With Siemens Solutions and Form an Engin...